default image

Urologie

Information and services of the department

  • Number of inpatient cases: 96

Services search (in the department)


Illness Number of cases
Hyperplasia of prostate (N40) 32
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 15
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) 14
Malignant neoplasm of prostate (C61) 7
Malignant neoplasm of testis (C62.1) not specified
Malignant neoplasm of bladder - Malignant neoplasm of trigone of bladder (C67.0) not specified
Malignant neoplasm of bladder - Malignant neoplasm of dome of bladder (C67.1) not specified
Malignant neoplasm of bladder - Malignant neoplasm of posterior wall of bladder (C67.4) not specified
Malignant neoplasm of bladder - Malignant neoplasm of bladder neck (C67.5) not specified
Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9) not specified
Treatment Number
Injection or administration of medicines into the urinary bladder (8-132.3) 84
Surgical creation of a connection between the urinary bladder and skin of the abdomen for artificial urinary drainage (5-572.1) 34
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 33
Exchange or removal of a urinary catheter through the abdominal wall (8-133.1) 32
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930) 28
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4) 26
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.1) 25
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1) 21
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 20
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41) 11

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
Number Group
31 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
31 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
31 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Initiation and management of uni-centric/multi-centric clinical/scientific studies Forschungsaktivität zum Thema Herzinfarktforschung in Kooperation mit dem KORA-Projekt Augsburg
Student training (clinical traineeship / internship year) Famulatur
No. Training in other healing professions Comment
HB19 Nursing professionals Kooperation Berufsfachschule für Pflege Donauwörth
HB05 Medical technical radiology assistant (MTRA) (m/f) Kooperation mit anderen Ausbildungsstätten

Vanessa Mielich

Leiter der Stabsstelle Qualitätsmanagement

Phone: 09082 -79-31930
Mail: ed.nekinilknod@hcileim.v

Vanessa Mielich

Leiter Stabsstelle Qualitätsmanagement

Phone: 09082 -79-0
Mail: ed.nekinilknod@hcileim.v

Prof, Dr. Bernhard Kuch

Ärztlicher Direktor

Phone: 09081 -299-20201
Mail: ed.nekinilknod@hcuk.b